Evidence-Based Integrative Medicine for Epidemics - LIDSEN Publishing Inc.丨The Open Access Publisher

Topical Collection

Evidence-Based Integrative Medicine for Epidemics

Editor

Gerhard Litscher, Univ.-Prof. Prof. hc mult. MSc PhD MDsc

Full professor at Swiss University of Traditional Chinese Medicine (SWISS TCM UNI), High-Tech Acupuncture and Digital Chinese Medicine, Switzerland

Website1 | Website2 | E-Mail

Research Interests: Evidence-based complementary medicine; integrative medicine; biomedical engineering; traditional Chinese medicine; neuromonitoring; high-tech acupuncture; digital Chinese medicine; laser medicine

Topical Collection Information

Evidence-Based Integrative medicine is an approach to care that puts the patient at the center and addresses the full range of physical, emotional, mental, social, spiritual and environmental influences that affect a person’s health. Employing a personalized strategy that considers the patient’s unique conditions, needs and circumstances, it uses the most appropriate interventions from an array of scientific disciplines to heal illness and disease and help people regain and maintain optimum health. In many cases, as evidence of efficacy and safety grows, these therapies are being combined with conventional medicine.

Evidence-based medicine (EBM) has great advantages in treating many diseases. It should be a new trend in treating epidemic diseases in the future. By Evidence-Based Integrative medicine, we can start to not only treat patients more effectively, but we can start to address the underlying lifestyle choices and emotional needs.

This special issue provides an open forum for researchers to share their research findings in the use of Evidence-Based Integrative medicine for epidemics disease. We welcome contributions in any form, including, original research, case report, review, etc.

Publication (8 papers)

2024

Jump to: 2023 2022 2021

Open Access Original Research

Evaluation of Add-On Individualized Homeopathic Medicines Products in the Treatment of Symptomatic COVID-19 Managed at Home: A Double Blind, Placebo-Controlled, Randomized, Exploratory Clinical Trial

Renata Lemonica ,

Isabela Almeida Cunha ,

Jéssica Layane Costa Melo ,

Sandra Regina Caram ,

José Eduardo Fuser Bittar and

Karina Pavao Patricio

Received: 23 March 2024; Published: 31 July 2024; doi: 10.21926/obm.icm.2403044

Abstract

Homeopathy has shown promise in fighting epidemics, leading to potential applications in the COVID-19 clinical cases. To assess the impact of add-on individualized homeopathic medicinal products (IHMP) in improving clinical outcomes and time to medical discharge in COVID-19 patients. A prospective, [...]

Open Access Original Research

The Symptomatic Expression in Chinese Patients with Suspected COVID-19 Omicron Variant Infection: A Clinical Case Registry Study

Alexander Tournier ,

Yvonne Fok ,

Robbert van Haselen and

Aaron To

Received: 29 February 2024; Published: 29 July 2024; doi: 10.21926/obm.icm.2403043

Abstract

Little systematic research has been conducted into the symptomatic expression of COVID-19 infections in patients. It is known that symptomatic expression varies between patients, but the nature and extent of this variability is poorly understood. This paper elaborates on the symptoms rep [...]

Open Access Case Report

Art of Telesupport of Caregiver during Myasthenia Gravis Crisis by COVID-19 Infection-Related Followed by Rescue in Late-Onset Patient

Corrado Angelini

Received: 06 February 2024; Published: 21 June 2024; doi: 10.21926/obm.icm.2402035

Abstract

An 83-year-old man with myasthenia gravis was hospitalized in the ICU; support for caregivers of elderly myasthenic patients in the ICU can be a crucial aspect of their care. Myasthenia gravis is a chronic autoimmune neuromuscular disease that can cause varying levels of muscle weakness, which can s [...]

Open Access Original Research

Erectile Function in Men during the COVID-19 Pandemic

Ludek Fiala

Received: 25 August 2023; Published: 18 February 2024; doi: 10.21926/obm.icm.2401014

Abstract

This research focused on two age groups of men (under 40 and over 40 years) and their sexual function during the COVID-19 pandemic. Somatic examinations, including the measurement of hormone levels, were conducted on all patients. The subjects also completed two questionnaires and provid [...]

Open Access Original Research

Medicament Testing in the Diagnosis of Long COVID Syndrome

Naylya Djumaeva ,

Gulnara Akhundjanova ,

Leyla Djumaeva and

Dilbar Urunova

Received: 08 October 2023; Published: 16 January 2024; doi: 10.21926/obm.icm.2401010

Abstract

Long COVID syndrome resulting from SARS-CoV-2 infection has a prevalence of 10%-35% in the population. Numerous studies of the disease are currently being conducted concerning the manifestations of long COVID syndrome; however, there are no data on the use of electroacupuncture diagnosis (EAV) and m [...]

2023

Jump to: 2024 2022 2021

Open Access Original Research

The Course of COVID: How the Pandemic Changed Art Therapy Practice

Deborah A. Sharpe and

Lisa D. Hinz

Received: 30 May 2023; Published: 19 July 2023; doi: 10.21926/obm.icm.2303029

Abstract

This study explored how the global COVID-19 pandemic changed the ways in which art therapists use art in their therapeutic practice. Art has repeatedly been linked to healing in a variety of settings, but generally art therapists have been accustomed to conducting therapy sessions in per [...]

2022

Jump to: 2024 2023 2021

Open Access Short Review

Review of Curcumin and Its Different Formulations: Pharmacokinetics, Pharmacodynamics and Pharmacokinetic-Pharmacodynamic Interactions

Suchandra Goswami ,

Shivangi Saxena ,

Shalini Yadav ,

Diptendu Goswami ,

Koushik Brahmachari ,

Sruti Karmakar ,

Biswajit Pramanik and

Sunil Brahmachari

Received: 22 May 2022; Published: 27 December 2022; doi: 10.21926/obm.icm.2204057

Abstract

Curcumin, the yellow principle of the Indian Turmeric, ‘Haldi’ has recently attracted renewed interest in the field of experimental medicine with pleiotropic activity. This review has emphasized three pharmaceutical studies of interest: the pharmacokinetics, pharmacology, and pharmacodynamics of cur [...]

2021

Jump to: 2024 2023 2022

Open Access Editorial

COVID-19 Lockdown in Wuhan: Heart Rate Variability in Females and Males – A Pilot Study

Gerhard Litscher ,

Li Tong and

Fengxia Liang

Received: 14 March 2021; Published: 15 March 2021; doi: 10.21926/obm.icm.2101009

Abstract

In a pioneer transcontinental pilot study conducted with 50 volunteers, it was revealed that women could have apparently overcome the world's toughest lockdown in terms of changes in the general state of health measured using the heart rate variability parameter better than men. The resu [...]